Identify suspicious moles, lesions, actinic keratoses, and non-healing spots through thorough full-body skin examinations and dermoscopic evaluation.


212.722.2055
Skin cancer treatment in NYC is provided by Dr. Marie V. Hayag, a board-certified dermatologist at her private Upper East Side Manhattan practice. Through comprehensive full-body skin examinations, dermoscopy, and biopsy when indicated, patients receive physician-led evaluation and personalized treatment focused on early detection, complete removal, and long-term skin health preservation.
Skin cancer is the most common cancer in the United States, affecting approximately 1 in 5 Americans by age 70. Early diagnosis significantly improves outcomes, particularly for melanoma. Patients throughout New York City trust Dr. Hayag for accurate diagnosis, thoughtful treatment planning, and structured ongoing surveillance in a private dermatology setting.






Identify suspicious moles, lesions, actinic keratoses, and non-healing spots through thorough full-body skin examinations and dermoscopic evaluation.
Differentiate benign growths from basal cell carcinoma (BCC), squamous cell carcinoma (SCC), melanoma, and dysplastic nevi using clinical expertise and skin biopsy when necessary.
Develop individualized treatment plans that prioritize complete cancer removal while preserving skin function and cosmetic outcomes whenever possible.
At Marie Hayag MD on Manhattan’s Upper East Side, skin cancer is treated as a serious medical condition requiring prompt, precise, and evidence-based management. Early detection and accurate risk stratification are essential to achieving optimal long-term outcomes.
Every evaluation includes assessment of:
This structured approach allows for accurate risk stratification and individualized monitoring plans.
When a diagnosis is confirmed, treatment is customized based on:
Care is designed to balance medical effectiveness with cosmetic sensitivity, especially important for facial and visible areas.
Skin cancer is the abnormal growth of skin cells caused primarily by cumulative ultraviolet (UV) radiation exposure. DNA damage from sun exposure or tanning devices triggers uncontrolled cell growth, which can develop into basal cell carcinoma, squamous cell carcinoma, or melanoma.
The three primary types include:
While many skin cancers are highly treatable when detected early, delayed diagnosis may allow deeper invasion or spread. Early evaluation by a board-certified dermatologist significantly improves outcomes.
Often appears as a pearly bump, pink patch, or non-healing sore. BCC rarely spreads but can cause local tissue damage if untreated.
May present as a scaly patch, crusted lesion, or firm red nodule. SCC carries a higher risk of spread than BCC if not treated promptly.
May arise from an existing mole or appear as a new pigmented lesion. Warning signs include asymmetry, irregular borders, color variation, diameter growth, or evolving features (ABCDE criteria). Early detection is critical.
A precancerous lesion caused by sun damage that may progress to SCC if untreated.
Accurate identification of lesion type is essential to guide proper treatment.
Early detection is the cornerstone of effective skin cancer treatment in New York City.
Each evaluation begins with a comprehensive examination of the skin, scalp, nails, and mucosal surfaces when indicated.
Advanced dermoscopy enhances visualization of pigmented and non-pigmented lesions to improve diagnostic accuracy.
If a lesion appears suspicious, a skin biopsy is performed under local anesthesia. Tissue is sent to pathology for definitive diagnosis.
Treatment Options May Include:
Each treatment plan is selected based on cancer type, depth, location, and recurrence risk while prioritizing patient safety and cosmetic outcome.
Dermatologist-led management provides:
Unlike non-specialized settings, board-certified dermatologic care ensures precise evaluation and evidence-based management.
A complete full-body skin exam identifies suspicious lesions, new moles, or changing growths.
Dermoscopy and biopsy confirm the diagnosis and determine cancer subtype and depth.
Treatment is selected based on medical necessity, cosmetic considerations, and long-term skin preservation.
Patients receive guidance on sun protection, UV avoidance, and follow-up intervals to monitor for recurrence or new lesions.
You may benefit from skin cancer screening in NYC if you:
High-risk individuals often require regular full-body skin exams.
Common warning signs include:
If you notice any of these changes, early dermatologic evaluation significantly improves treatment outcomes.
At her Upper East Side Manhattan practice, Dr. Marie V. Hayag provides physician-led skin cancer evaluation and treatment focused on early detection, precise diagnosis, and long-term skin preservation.
If you have concerns about a mole, lesion, or changing spot or wish to schedule a routine annual skin cancer screening, contact our office today.
Call 212.722.2055 or book online to schedule your skin cancer evaluation in NYC.
Patients throughout Manhattan and New York City trust board-certified dermatologist Dr. Hayag for expert, medically focused skin cancer care in a private setting.
Early signs include new or changing moles, non-healing sores, pearly bumps, scaly patches, or rapidly evolving pigmented lesions. Any suspicious change warrants evaluation.
Most skin cancers are highly treatable when detected early. Early-stage basal cell and squamous cell carcinomas have excellent cure rates. Melanoma survival rates improve significantly with early diagnosis and prompt treatment.
Melanoma may appear asymmetric, have irregular borders, multiple colors, or evolve over time. The ABCDE rule helps identify concerning features.
Treatment may include surgical excision, Mohs surgery, destructive therapies, topical treatments, or surveillance depending on the diagnosis.
Most adults benefit from annual full-body skin exams. Individuals with a personal history of skin cancer, many atypical moles, or significant sun exposure may require more frequent dermatologic evaluation.
Yes. While basal cell carcinoma rarely spreads, squamous cell carcinoma and melanoma can metastasize if untreated. Early treatment reduces this risk.
Schedule a personalized consultation with Marie Hayag MD and her experienced team to receive physician-guided skin cancer evaluation and treatment tailored to your individual needs.





212.722.2055